Pfizer to appeal India decision to revoke cancer drug patent Reuters via Yahoo! Canada News Fri, 05 Oct 2012 00:18 AM PDT MUMBAI (Reuters) - Pfizer Ltd, the India unit of U.S. drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug Sutent. The company, which will appeal before the Intellectual Property Appellate Board, said on Friday the Indian Patent Office's decision raised concerns over India's commitment to protect intellectual property. "We believe the ... | | |
|
No comments:
Post a Comment